Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients

The most common primary malignant bone sarcoma is Osteogenic sarcoma (OS) which has a bimodal age distribution. Unfortunately, the treatment of OS was less effective for elderly patients than for younger ones. The study aimed to explore a new microRNA (miRNA) which can bind to combining engineered e...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyu Han, Zitong Zhao, Yanhong Wang, Tao Yu, Daqian Wan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.1052252/full
Tags: Add Tag
No Tags, Be the first to tag this record!